DALE MITCHELL
Senior Director Small Molecule Drug Discovery
Charles River Laboratories
Dale has worked for Charles River and legacy companies since 2000 and has 37 years’ experience in the pharmaceutical and agrochemical industries. Dale has led a wide range of collaborative programs in areas such as inflammation, oncology, anti-infectives, neurodegeneration and PET imaging. In his current role, Dale provides strategic oversight on integrated drug discovery programs, working closely with multi-disciplinary project teams and partners to generate hit compounds, deliver lead series and identify pre-clinical candidates.
SARAH GOULD
Director Senior Principle Scientific Advisor
Charles River Laboratories
Senior regulatory pharmaco-toxicologist and program manager with extensive experience (18 years) working for blue-chip, international pharmaceutical companies. I have a proven track record of effective delivery, bringing small and large molecule projects forward to clear
decision milestones, submissions to, and interactions with health authorities up to licence (eg IND's, IMPD's, CTD's etc), with full knowledge of GLP/GXP standards and regulatory guidelines (ICH, CHMP, FDA, WHO).
Online via Zoom | Please register HERE!
Registration to the webinar is required in advance. Please note that you will receive the Zoom link and access code the evening before the lecture and that access to last minute registrations, cannot be guaranteed. By participating in this webinar, you consent to the sharing of your email address with our SPARK Partners for the sole purpose of providing information and resources related to their certification programs. Your information will not be used for any other purpose without your explicit consent.
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland, SPARK Tel Aviv, SPARK Denmark, SPARK Zürich and SPARK at the Faculty of Medicine, Masaryk University. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
